Immunosuppression with cyclophosphamide in the dog.
Cyclophosphamide significantly diminished the canine humoral antibody response to sheep red blood cells and tended to prevent arterial lesions in renal homografts. However, cyclophosphamide failed to prolong renal homograft survival when administered to dogs as the sole immunosuppressive agent, and it did not add to the effectiveness of azathioprine when given as a supplement to the azathioprine and administered simultaneously or sequentially.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000494:pharmacology* / Q000627:therapeutic use; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000276:immunology; D006084:Graft Rejection; D006388:Hemagglutinins; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D007970:Leukopenia; D008297:Male; D014184:Transplantation, Homologous
D006388:Hemagglutinins; D003520:Cyclophosphamide; D001379:Azathioprine